Fmr LLC sold $1.9M of SANA
owner, other at Sana Biotechnology, Inc.. 290,912 shares at an average of $6.49, traded Jan 8, 2025, filed Jan 10, 2025.
Score components
- +12Role10% owner
- +25Trade size$1.9M at market
- 0Share of holdings soldSold 6.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -18.3%, 3m -51.9%, 6m +14.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-004052, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 8, 2025 | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -100,000 | $6.11 | $611k | 4,732,423 | Jan 10, 2025 |
| Jan 8, 2025 | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -25,000 | $6.50 | $163k | 4,707,423 | Jan 10, 2025 |
| Jan 8, 2025 | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -164,912 | $6.71 | $1.1M | 4,542,511 | Jan 10, 2025 |
| Jan 8, 2025 | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -1,000 | $7.26 | $7,260 | 4,541,511 | Jan 10, 2025 |
Related signals
Other insiders at Sana Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 9Weak | Sana Biotechnology, Inc. | Christian Hordo EVP, Chief Business Officer | $300k 75,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.